A Standardized Approach to Quantitative Analysis of Nicotine in e-Liquids Based on Peak Purity Criteria Using High-Performance Liquid Chromatography

por Gholap, Vinit V., Kosmider, Leon, Halquist, Matthew S.
Publicado 2018

Characterization of molecularly imprinted polymers for the extraction of tobacco alkaloids and their metabolites in human urine

por Mulder, Haley A., Pearcy, Adam C., Halquist, Matthew S.
Publicado 2022

An Analytical Perspective on Determination of Free Base Nicotine in E-Liquids

por Gholap, Vinit V., Heyder, Rodrigo S., Kosmider, Leon, Halquist, Matthew S.
Publicado 2020

E-Liquids from Seven European Countries–Warnings Analysis and Freebase Nicotine Content

por Bębenek, Patryk Krystian, Gholap, Vinit, Halquist, Matthew, Sobczak, Andrzej, Kośmider, Leon
Publicado 2022

Simvastatin promotes NPC1‐mediated free cholesterol efflux from lysosomes through CYP7A1/LXRα signalling pathway in oxLDL‐loaded macrophages

por Xu, Xiaoyang, Zhang, Aolin, Halquist, Matthew S., Yuan, Xinxu, Henderson, Scott C., Dewey, William L., Li, Pin‐Lan, Li, Ningjun, Zhang, Fan
Publicado 2016

The Effect of Electronic Cigarette User Modifications and E-liquid Adulteration on the Particle Size Profile of an Aerosolized Product

por Mulder, Haley A., Patterson, Jesse L., Halquist, Matthew S., Kosmider, Leon, Turner, Joseph B. McGee, Poklis, Justin L, Poklis, Alphonse, Peace, Michelle R.
Publicado 2019

Author Correction: The Effect of Electronic Cigarette User Modifications and E-liquid Adulteration on the Particle Size Profile of an Aerosolized Product

por Mulder, Haley A., Patterson, Jesse L., Halquist, Matthew S., Kosmider, Leon, Turner, Joseph B. McGee, Poklis, Justin L., Poklis, Alphonse, Peace, Michelle R.
Publicado 2020

An examination of social and environmental determinants of secondhand smoke exposure among non-smoking adolescents

por Do, Elizabeth K., Bradley, Kennedy C., Fugate-Laus, Kendall, Kaur, Kiranpreet, Halquist, Matthew S., Ray, Laure, Pope, Michell A., Hayes, Rashelle B., Wheeler, David C., Fuemmeler, Bernard F.
Publicado 2021

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers

por Wohlford, George F., Buckley, Leo F., Kadariya, Dinesh, Park, Taeshik, Chiabrando, Juan Guido, Carbone, Salvatore, Mihalick, Virginia, Halquist, Matthew S., Pearcy, Adam, Austin, Dana, Gelber, Cohava, Abbate, Antonio, Van Tassell, Benjamin
Publicado 2021